HOW WE CAN HELP
Our practice areas provide focused decision support to business-critical functional areas. Our therapy and capability teams provide the support needed to bring the right context, knowledge and tools to our engagements.
As a partner committed to the success of your business, SAI is uniquely positioned to help you maintain your competitive edge. Our global team possesses a unique combination of clinical and commercial expertise, enabling key insights and appropriate context in support of our clients’ strategic planning process.
Meanwhile, our therapy and capability teams provide the right context, knowledge and analytical tools to our engagements, along with the ability to incorporate specific therapeutic area nuances into our analysis.
FUNCTIONS WE SUPPORT
SAI regularly supports pricing and market access strategy development around the globe with a range of services designed to help ensure optimal access and reimbursement for our clients. Leveraging our team’s deep pricing and outcomes research expertise and real-world payer industry experience, we help clients:
- Determine optimal price levels and value dossiers
- Evaluate optimal outcomes-research programs
- Conduct country-level stakeholder influence assessments across public and private payer sectors
- Benchmark and assess specific contracting strategies with payers and physicians
With over 175 consultants globally and an organizational footprint across key emerging markets, SAI regularly supports geographic growth strategies around the world. Leveraging our deep understanding of local market dynamics, local language fluency and on-the-ground presence in key markets throughout Asia, Latin America and Eastern Europe we help our clients:
- Assess optional acquisition targets or partnership opportunities
- Understand local treatment paradigms and market access nuances
- Understand competitive dynamics and potential entry barriers
SAI works extensively with BD&L executives as well as R&D groups in support of growth strategies and portfolio optimization efforts, specific support programs that target “de-risking” investment initiatives or maximize asset potential in a number of ways:
- Commercial and clinical/regulatory due diligence programs
- Stage-gate growth and licensing initiatives to bolster existing portfolios
- Integrated portfolio reviews
SAI’s team of seasoned pharmaceutical executives can provide critical support in helping clients increase the trajectory of product launches and optimization of a product lifecycle in a number of ways:
- Organizational and resource benchmarking
- “Best practice” analogue assessments
- Promotional and messaging research
- Patient adherence program recommendations
- Competitive gaming and scenario planning workshops
SAI’s Biosimilars practice is comprised of highly specialized consultant and analyst teams with prior experience in biologics manufacturing and biosimilar development and help clients navigate this complex and rapidly evolving field in several different ways:
- Biosimilars competitive landscape analysis in developed and emerging market countries
- Assessing various Pricing, Market Access and Commercial Strategies
- Regulatory environment mapping
- Supply Chain and Manufacturing benchmarking
SAI possesses an in-depth understanding of the global generic drug market and we routinely help clients understand the risks and opportunities when brands approach loss of exclusivity. With a broad range of clients in the generic and branded pharmaceutical industries, we help our clients optimize their strategies and exploit market opportunities using:
- Market opportunity assessment
- API partnering and business development support
- Brand defense strategy development
- Mature brand portfolio optimization
SAI has extensive experience in strategic consulting to guide portfolio decision making. Our core competency in competitive intelligence coupled with in depth experience and insights position SAI as an excellent partner to drive well-informed, de-risked portfolio decisions:
- Thorough analysis of therapeutic area trends, market dynamics, competitive landscape, regulatory environment, and payer reimbursement space to inform portfolio strategy teams
- Broad portfolio analysis across therapeutic areas, technologies, and regions
- Analysis of a specific therapeutic area or technology to de-risk M&A, trial investment, or life-cycle management of mature brands
SAI’s clinical team has broad experience in supporting R&D teams from preclinical to launch. Our team has real-world experience to drive forward looking insights and implications to support internal investment decisions:
- Market analysis and opportunity assessment – current and future landscape
- Competitive landscape and analysis of dynamic treatment paradigms
- Clinical trial dynamics and benchmarking
SAI’s team of commercially experienced pharmaceutical executives can provide actionable market intelligence to support clients who seek a better understanding of what is happening “on the ground” across all therapy areas. SAI is experienced in providing their clients with the insights into the following:
- Product messaging and counter-messaging
- Promotion materials
- Sales force size, bag weightings and co-promotes
- Overall brand strategies including insights and analysis of patient and physician education programs
- Launch plans – including launch dates, go-to-market strategies, conference attendance, etc.